SE9403953D0 - Sequence-based diagnosis - Google Patents
Sequence-based diagnosisInfo
- Publication number
- SE9403953D0 SE9403953D0 SE9403953A SE9403953A SE9403953D0 SE 9403953 D0 SE9403953 D0 SE 9403953D0 SE 9403953 A SE9403953 A SE 9403953A SE 9403953 A SE9403953 A SE 9403953A SE 9403953 D0 SE9403953 D0 SE 9403953D0
- Authority
- SE
- Sweden
- Prior art keywords
- sequence
- neoplasia
- based diagnosis
- mutations
- prognosticating
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 4
- 230000035772 mutation Effects 0.000 abstract 3
- 230000009826 neoplastic cell growth Effects 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 230000008827 biological function Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9403953A SE9403953D0 (sv) | 1994-07-15 | 1994-11-16 | Sequence-based diagnosis |
| EP95926065A EP0769069A1 (en) | 1994-07-15 | 1995-06-29 | Sequence-based mutation analysis of neoplastic tissue for diagnosis or prognosis of the neoplasia |
| US08/776,044 US20020142295A1 (en) | 1994-07-15 | 1995-06-29 | Sequence-based mutation analysis of neoplastic tissue for diagnosis or prognosis of the neoplasia |
| PCT/SE1995/000804 WO1996002671A1 (en) | 1994-07-15 | 1995-06-29 | Sequence-based mutation analysis of neoplastic tissue for diagnosis or prognosis of the neoplasia |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9402487A SE9402487D0 (sv) | 1994-07-15 | 1994-07-15 | Sequence-based diagnosis |
| SE9403953A SE9403953D0 (sv) | 1994-07-15 | 1994-11-16 | Sequence-based diagnosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9403953D0 true SE9403953D0 (sv) | 1994-11-16 |
Family
ID=26662098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9403953A SE9403953D0 (sv) | 1994-07-15 | 1994-11-16 | Sequence-based diagnosis |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20020142295A1 (xx) |
| EP (1) | EP0769069A1 (xx) |
| SE (1) | SE9403953D0 (xx) |
| WO (1) | WO1996002671A1 (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2473900A (en) * | 1998-11-23 | 2000-06-13 | Exact Sciences Corporation | Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids |
| WO2006047787A2 (en) | 2004-10-27 | 2006-05-04 | Exact Sciences Corporation | Method for monitoring disease progression or recurrence |
| WO2007044071A2 (en) | 2005-04-21 | 2007-04-19 | Exact Sciences Corporation | Analysis of heterogeneous nucleic acid samples |
| WO2007039705A1 (en) * | 2005-10-05 | 2007-04-12 | Astrazeneca Uk Limited | Method to predict or monitor the response of a patient to an erbb receptor drug |
| AU2017263319A1 (en) * | 2016-05-09 | 2018-12-13 | Human Longevity, Inc. | Methods of determining genomic health risk |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| EP0390323B2 (en) * | 1989-03-29 | 2012-08-08 | Johns Hopkins University | Detection of loss of the wild-type p53 gene |
| DE69233079T2 (de) * | 1991-02-01 | 2004-04-01 | OSI Pharmaceuticals, Inc., Uniondale | Immunoassay zum nachweis des mutanten p53 polypeptids in biologischen flüssigkeiten |
| GB9114525D0 (en) * | 1991-07-05 | 1991-08-21 | Delnatte Sabine | Homogeneous nucleic acids probe based tests and substances |
-
1994
- 1994-11-16 SE SE9403953A patent/SE9403953D0/xx unknown
-
1995
- 1995-06-29 US US08/776,044 patent/US20020142295A1/en not_active Abandoned
- 1995-06-29 EP EP95926065A patent/EP0769069A1/en not_active Withdrawn
- 1995-06-29 WO PCT/SE1995/000804 patent/WO1996002671A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996002671A1 (en) | 1996-02-01 |
| EP0769069A1 (en) | 1997-04-23 |
| US20020142295A1 (en) | 2002-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9814386B1 (pt) | aparelhos e métodos para determinar a concentração de um componente medicamente significante de um fluido biológico. | |
| ZA200202942B (en) | Elisa for VEGF. | |
| ATE530671T1 (de) | Verbindungen und verfahren zur diagnose von tuberkulose | |
| HUP0203705A2 (hu) | Vegyületek és eljárások Chlamydia-fertőzés kezelésére és diagnózisára | |
| WO2006128192A3 (en) | Use of free circulating dna for diagnosis, prognosis, and treatment of cancer | |
| AU2002334989A1 (en) | Methods, compositions, and automated systems for separating rare cells from fluid samples | |
| NO995690L (no) | Forbindelser for diagnose av tuberkulose og metoder for deres anvendelse | |
| ATE233824T1 (de) | Molekulare diagnose von familiärer adenomatöser polyposis | |
| ATE283485T1 (de) | Verfahren zur diagnose und zur charakterisierung von schlaganfall | |
| EP1480251A3 (en) | System of analyzing complex mixtures of biological and other fluids to identify biological state information | |
| EP1291422A3 (de) | Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe | |
| EP1612280A3 (en) | Diagnosis and treatment of Williams syndrome | |
| ATE168135T1 (de) | Diagnose von retinoblastoma | |
| DE69636749D1 (de) | Methode zur bestimmung von proteinfragmenten in körperflüssigkeiten | |
| SE9403953D0 (sv) | Sequence-based diagnosis | |
| DE69204157D1 (de) | Verfahren zur bestimmung von anti-rns-antikörpern. | |
| AU2254792A (en) | Pen polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic application thereof | |
| DE50105971D1 (de) | Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 125 | |
| DE69636041D1 (de) | Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen | |
| DE69132144D1 (de) | Menschliche phospholipase aktivierender proteinteil | |
| EP0870036A4 (en) | SYNTHETIC MAMMAL ALPHA-N-AECTYL GLUCOSAMINIDASE AND ENCODING GENETIC SEQUENCES THEREFOR | |
| FI990380A7 (fi) | Diagnostinen ja seulontamenetelmä | |
| FR2791357B1 (fr) | Diagnostic de la maladie de whipple | |
| AU2003299389A8 (en) | PRP detection method using an aminoglycoside antibiotic | |
| DE69934236D1 (de) | Proteoglykan (azaftig) zur überwachung von kachexie und zur fettleibigkeitskontrolle |